This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Latency reversal plus natural killer cells diminish HIV reservoir in vivo
Nature Communications Open Access 10 January 2022
-
Induced pluripotent stem cells in hematology: current and future applications
Blood Cancer Journal Open Access 09 May 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S . Functions of natural killer cells. Nat Immunol 2008; 9: 503–510.
Yagita M, Huang CL, Umehara H, Matsuo Y, Tabata R, Miyake M et al. A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation. Leukemia 2000; 14: 922–930.
Gong JH, Maki G, Klingemann HG . Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia 1994; 8: 652–658.
Yodoi J, Teshigawara K, Nikaido T, Fukui K, Noma T, Honjo T et al. TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells). J Immunol 1985; 134: 1623–1630.
Kornbluth J, Flomenberg N, Dupont B . Cell surface phenotype of a cloned line of human natural killer cells. J Immunol 1982; 129: 2831–2837.
Robertson MJ, Cochran KJ, Cameron C, Le JM, Tantravahi R, Ritz J . Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp Hematol 1996; 24: 406–415.
Uphoff CC, Denkmann SA, Steube KG, Drexler HG . Detection of EBV, HBV, HCV, HIV-1, HTLV-I and -II, and SMRV in human and other primate cell lines. J Biomed Biotechnol 2010; 2010: 904767.
Biesinger B, Mueller-Fleckenstein I, Simmer B, Lang G, Wittmann S, Platzer E et al. Stable growth transformation of human T lymphocytes by herpesvirus saimiri. Proc Natl Acad Sci USA 1992; 89: 3116–3119.
Heck E, Friedrich U, Gack MU, Lengenfelder D, Schmidt M, Mueller-Fleckenstein I et al. Growth transformation of human T cells by herpesvirus saimiri requires multiple Tip-Lck interaction motifs. J Virol 2006; 80: 9934–9942.
Stephan V, Wahn V, Le DF, Dirksen U, Broker B, Mueller-Fleckenstein I et al. Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells. N Engl J Med 1996; 335: 1563–1567.
Pacheco-Castro A, Al varez-Zapata D, Serrano-Torres P, Regueiro JR . Signaling through a CD3 gamma-deficient TCR/CD3 complex in immortalized mature CD4+ and CD8+ T lymphocytes. J Immunol 1998; 161: 3152–3160.
Crequer A, Troeger A, Patin E, Ma CS, Picard C, Pedergnana V et al. Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections. J Clin Invest 2012; 122: 3239–3247.
Zielke K, Full F, Teufert N, Schmidt M, Mueller-Fleckenstein I, Alberter B et al. The insulator protein CTCF binding sites in the orf73/LANA promoter region of herpesvirus saimiri are involved in conferring episomal stability in latently infected human T cells. J Virol 2012; 86: 1862–1873.
Toptan T, Ensser A, Fickenscher H . Rhadinovirus vector-derived human telomerase reverse transcriptase expression in primary T cells. Gene Ther 2010; 17: 653–661.
Knappe A, Feldmann G, Dittmer U, Meinl E, Nisslein T, Wittmann S et al. Herpesvirus saimiri-transformed macaque T cells are tolerated and do not cause lymphoma after autologous reinfusion. Blood 2000; 95: 3256–3261.
Acknowledgements
We thank Monika Schmidt, Doris Lengenfelder and Brigitte Scholz for tissue culture advice and Bernhard Fleckenstein for helpful discussions and continuous support. We thank Georg Fey for ARH77 and SEM cells. This work was supported by grants to AE by DFG collaborative research center SFB796 and international graduate school GRK 1071, and the Wilhelm Sander Stiftung 2009.002.1, and the ‘Novartis Stiftung für therapeutische Forschung’ for providing an individual fellowship to FF.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Benjamin Vogel and Armin Ensser filed a patent to the German Patent Office involving applications of virus-transformed NK cells. This does not alter our adherence to all Leukemia policies on sharing data and materials.
Additional information
Author contributions
BV carried out the experiments, KT and FF provided important reagents, BV and AE designed the experiments and wrote the paper.
Supplementary Information accompanies this paper on the Leukemia website
Rights and permissions
About this article
Cite this article
Vogel, B., Tennert, K., Full, F. et al. Efficient generation of human natural killer cell lines by viral transformation. Leukemia 28, 192–195 (2014). https://doi.org/10.1038/leu.2013.188
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2013.188
This article is cited by
-
Latency reversal plus natural killer cells diminish HIV reservoir in vivo
Nature Communications (2022)
-
Induced pluripotent stem cells in hematology: current and future applications
Blood Cancer Journal (2014)